{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CNY", "exchange": "SHH", "shortName": "BEIJING KAWIN TECHNOLOGY SHARE-", "longName": "Beijing Kawin Technology Share-Holding Co., Ltd.", "messageBoardId": "finmb_61417238", "market": "cn_market", "marketState": "POSTPOST", "trailingAnnualDividendRate": 0.2, "trailingPE": 55.652172, "trailingAnnualDividendYield": 0.007849294, "epsTrailingTwelveMonths": 0.46, "sharesOutstanding": 170908000, "bookValue": 10.107, "fiftyDayAverage": 28.0616, "fiftyDayAverageChange": -2.4615993, "fiftyDayAverageChangePercent": -0.08772127, "twoHundredDayAverage": 22.23215, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Shanghai", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": 0.47096094, "regularMarketPrice": 25.6, "regularMarketChange": 0.12000084, "regularMarketTime": 1683874802, "regularMarketDayHigh": 25.8, "regularMarketDayRange": "25.23 - 25.8", "regularMarketDayLow": 25.23, "regularMarketVolume": 736620, "regularMarketPreviousClose": 25.48, "bid": 25.59, "ask": 25.6, "fullExchangeName": "Shanghai", "financialCurrency": "CNY", "regularMarketOpen": 25.23, "averageDailyVolume3Month": 2345295, "averageDailyVolume10Day": 2385276, "fiftyTwoWeekLowChange": 10.84, "fiftyTwoWeekLowChangePercent": 0.7344173, "fiftyTwoWeekRange": "14.76 - 33.3", "fiftyTwoWeekHighChange": -7.699999, "fiftyTwoWeekHighChangePercent": -0.2312312, "fiftyTwoWeekLow": 14.76, "fiftyTwoWeekHigh": 33.3, "twoHundredDayAverageChange": 3.3678513, "twoHundredDayAverageChangePercent": 0.15148564, "marketCap": 4375244800, "priceToBook": 2.532898, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.0 - Strong Buy", "firstTradeDateMilliseconds": 1612747800000, "priceHint": 2, "symbol": "688687.SS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building 3, No. 6, Rongjing East Street", "address2": "Beijing Economic and Technological Development Zone", "city": "Beijing", "zip": "100176", "country": "China", "phone": "86 10 6789 2271", "fax": "86 10 6789 2271", "website": "https://www.kawin.com.cn", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Beijing Kawin Technology Share-Holding Co., Ltd. engages in the development and production of pharmaceutical products primarily in the areas of liver diseases in China. The company's products include recombinant human interferon alfa-2b injection and compound glycyrrhizin. It provides active pharmaceutical ingredients; clinical research services for biological product development, which include drug substances\u0096fermentation and purification, drug product\u0096formulation, and analytical methods development; and contract manufacturing services. The company also serves customers in Pakistan, Colombia, Philippines, Vietnam, Russia, Cambodia, and others. It has strategic partnership with Legend Capital, Haitong Capital, and Cybernaut. The company was founded in 2008 and is based in Beijing, China.", "fullTimeEmployees": 681, "companyOfficers": [{"maxAge": 1, "name": "Mr. Desheng  Zhou", "age": 51, "title": "Gen. Mang. and Chairman", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wei  Guo", "age": 36, "title": "Chief Financial Officer", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tao  Wang", "age": 54, "title": "Chief Research Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Chongfei  He", "age": 53, "title": "Deputy Gen. Mang. & Board Sec. and Director", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jifeng  Shi", "age": 48, "title": "Deputy Gen. Mang. and Director", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jianhua  Hou", "age": 45, "title": "Director of Beiyi Protein", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Dongxia  Li", "age": 48, "title": "VP of Beiyi Protein", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}